Archive for 2007/03


Hospitals Improve Quality Of Care For Three Conditions, According To Study

U.S. hospitals have made improvements in the care provided to heart attack, heart failure and pneumonia patients, according to a report released on Tuesday by the Joint Commission, AP/Long Island Newsday reports. [click link for full article]
(more...)


Updated Varian Brachytherapy Applicator Set For Esophagus Cancer Treatment Receives FDA 510k Clearance

Varian Medical Systems has received 510k clearance from the U.S. Food and Drug Administration (FDA) to market an updated brachytherapy applicator set designed specifically for intraluminal treatment of cancer of the esophagus. The Esophagus Bougie Set(TM) can now be used with Varian's full range of VariSource(R) and GammaMed(R) HDR (high dose rate) afterloaders. [click link for full article]
(more...)


Alternative Medicine: The Christian Handbook, New Edition Available

Christian Medical Association is pleased to announce their latest "Medically Reliable and Biblically Sound" publication Alternative Medicine: The Christian Handbook Updated and Expanded, (Zondervan, 2007) written by Dónal O'Mathúna, PhD and Walt Larimore, MD. "A much-needed resource for the consumer as well as healthcare providers. The use of alternative medicine is increasing particularly among Christians. [click link for full article]
(more...)


XDR-TB Threatens To Undo Progress Against HIV/AIDS In Africa, Editorial Says

The spread of extensively drug-resistant tuberculosis -- TB that is resistant to the two most potent first-line treatments and some of the available second-line drugs -- is one of the "acute" threats to progress in combating HIV/AIDS in Africa, a Boston Globe editorial says. [click link for full article]
(more...)


Fibrosing Mediastinitis (FM), A Rare Lung Disease

Below is a letter from Gina Starks to Medical News Today, who suffers from Fibrosing Mediastinitis (FM), a rare lung disease:Dear Medical News Today, My name is Gina Starks. I am 29 years old, married and have a two-year-old son. I also happen to be battling a very rare and life threatening lung disease. Fibrosing Mediastinitis (FM). I developed this disease as a result of living in the Midwest. [click link for full article]
(more...)


Results Of New Blood Tests For TB

Two new interferon-gamma blood test assays to detect latent tuberculosis infection (LTBI) showed customers were exposed to a supermarket employee in Holland who had smear-positive tuberculosis, while traditional tuberculin skin tests (TST) did not, according to a large contact study.Results from these tests were published in the second issue for March 2007 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society. [click link for full article]
(more...)


Asthmatic Children Still Not Breathing Easier, Study Says

Only 20 percent of children with persistent asthma have a level of control that is optimal, according to a survey-based study published in the Journal of Ambulatory Pediatrics."That leaves almost 80 percent who are suffering more than they need to," said the study's lead author, Jill Halterman, M.D., M.P.H., Associate Professor of Pediatrics at Golisano Children's Hospital at Strong. [click link for full article]
(more...)


African Reliance On Traditional Medicine For The Treatment Of HIV/AIDS

A paper by Aceme Nyika, published this week in Developing World Bioethics examines the reliance on traditional medicine by HIV/AIDS sufferers in Africa, due to the affordability of traditional medicine in comparison to orthodox medicine. [click link for full article]
(more...)


A Closer Look Inside Our Lungs — Penn Researchers Develop 2 Novel Imaging Techniques

Researchers at the University of Pennsylvania School of Medicine are harnessing two new, non-invasive techniques to look more closely inside the working lungs - leading to early detection of diseases, like emphysema, before it becomes evident in other modes of imaging. [click link for full article]
(more...)


Respironics’ I-neb(R) Device Utilized In Clinical Evaluation Of Interferon Gamma In Idiopathic Pulmonary Fibrosis Patients

Respironics, Inc. (Nasdaq: RESP) today announced that it has formed an agreement with The State University of New York (SUNY) and New York University School of Medicine (NYU) to utilize the I-neb Adaptive Aerosol Delivery (AAD(R)) System for clinical evaluation of aerosolized Interferon Gamma for the treatment of Idiopathic Pulmonary Fibrosis (IPF). The clinical trial will take place over a two-year time period. [click link for full article]
(more...)